New pilot study shows two doses of psilocybin reduced symptom burden by ~40% in people with post-treatment Lyme disease (PTLD), with improvements in pain, fatigue, sleep, and mood lasting up to 6 months. Findings are still very preliminary, but suggests psilocybin may be a new avenue for treating PTLD and possibly similar illnesses.
Psilocybin Shows Lasting Benefits for Patients with Post-Treatment Lyme Disease : Johns Hopkins Lyme Disease Research Center
Summary A Johns Hopkins pilot study found that psilocybin, given with psychological support, was safe and well tolerated in adults with post-treatment Lyme disease and was associated with significant, lasting […]
www.hopkinslyme.org
I have a friend with Lyme so this could be massive for him! I'm sure he would welcome a 40% benefit in his symptoms.